Does EVOLOCUMAB Cause Wrong technique in product usage process? 21,664 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 21,664 reports of Wrong technique in product usage process have been filed in association with EVOLOCUMAB (REPATHA). This represents 14.5% of all adverse event reports for EVOLOCUMAB.
21,664
Reports of Wrong technique in product usage process with EVOLOCUMAB
14.5%
of all EVOLOCUMAB reports
4
Deaths
285
Hospitalizations
How Dangerous Is Wrong technique in product usage process From EVOLOCUMAB?
Of the 21,664 reports, 4 (0.0%) resulted in death, 285 (1.3%) required hospitalization, and 15 (0.1%) were considered life-threatening.
Is Wrong technique in product usage process Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 21,664 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
Device use error (4,002)
What Other Drugs Cause Wrong technique in product usage process?
ALBUTEROL (17,114)
ADALIMUMAB (11,766)
PEGFILGRASTIM (10,217)
ETANERCEPT (9,835)
ERENUMAB-AOOE (9,359)
SACUBITRIL\VALSARTAN (8,022)
LEUPROLIDE (5,062)
FENTANYL (2,812)
SEMAGLUTIDE (2,538)
DICLOFENAC (2,298)
Which EVOLOCUMAB Alternatives Have Lower Wrong technique in product usage process Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE